|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oh CM, Won YJ, Jung KW, Kong HJ, Cho H,
Lee JK, Lee DH and Lee KH; Community of Population-Based Regional
Cancer Registries, : Cancer statistics in Korea: Incidence,
mortality, survival, and prevalence in 2013. Cancer Res Treat.
48:436–450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng H, Zheng R, Zhang S, Zuo T, Xia C,
Zou X and Chen W: Esophageal cancer statistics in China, 2011:
Estimates based on 177 cancer registries. Thorac Cancer. 7:232–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Essadi I, Lalya I and Mansouri H:
Esophageal carcinoma. N Engl J Med. 372:1470–1471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun
ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of
esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang SD, Yuan Y, Zhuang CW, Li BL, Gong
DJ, Wang SG, Zeng ZY and Cheng HZ: MicroRNA-98 and microRNA-214
post-transcriptionally regulate enhancer of zeste homolog 2 and
inhibit migration and invasion in human esophageal squamous cell
carcinoma. Mol Cancer. 11:512012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun M and Kraus WL: From discovery to
function: The expanding roles of long noncoding RNAs in physiology
and disease. Endocr Rev. 36:25–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lalevee S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 7:877–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY,
Xue WQ, Chen YB, Zhang Y and Jia WH: HOTAIR, a prognostic factor in
esophageal squamous cell carcinoma, inhibits WIF-1 expression and
activates Wnt pathway. Cancer Sci. 104:1675–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren K, Li Y, Lu H, Li Z, Li Z, Wu K, Li Z
and Han X: Long noncoding RNA HOTAIR controls cell cycle by
functioning as a competing endogenous RNA in esophageal squamous
cell carcinoma. Transl Oncol. 9:489–497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu C, Yang L, Chen H and Shan Z:
Upregulated long non-coding RNA BC032469 enhances carcinogenesis
and metastasis of esophageal squamous cell carcinoma through
regulating hTERT expression. Tumour Biol. Oct 10–2016.(Epub ahead
of print). doi: 10.1007/s13277-016-5428-9. View Article : Google Scholar
|
|
20
|
Chen X, Han H, Li Y, Zhang Q, Mo K and
Chen S: Upregulation of long noncoding RNA HOTTIP promotes
metastasis of esophageal squamous cell carcinoma via induction of
EMT. Oncotarget. 7:84480–84485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y
and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes
to proliferation and metastasis in esophageal squamous cell
carcinoma. J Exp Clin Cancer Res. 34:72015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thum T and Fiedler J: LINCing MALAT1 and
angiogenesis. Circ Res. 114:1366–1368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gutschner T, Hammerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shan H, Yang Y, Zhu X, Han X, Zhang P and
Zhang X: FAM83H-AS1 is associated with clinical progression and
modulates cell proliferation, migration, and invasion in bladder
cancer. J Cell Biochem. 120:4687–4693. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu S, Dong W, Zhao P and Liu Z: lncRNA
FAM83H-AS1 is associated with the prognosis of colorectal carcinoma
and promotes cell proliferation by targeting the Notch signaling
pathway. Oncol Lett. 15:1861–1868. 2018.PubMed/NCBI
|
|
27
|
Yang L, Xu L, Wang Q, Wang M and An G:
Dysregulation of long non-coding RNA profiles in human colorectal
cancer and its association with overall survival. Oncol Lett.
12:4068–4074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Feng S, Su W, Bai S, Xiao L, Wang
L, Thomas DG, Lin J, Reddy RM, Carrott PW, et al: Overexpression of
FAM83H-AS1 indicates poor patient survival and knockdown impairs
cell proliferation and invasion via MET/EGFR signaling in lung
cancer. Sci Rep. 7:428192017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arnes L, Liu Z, Wang J, Maurer C,
Sagalovskiy I, Sanchez-Martin M, Bommakanti N, Garofalo DC,
Balderes DA, Sussel L, et al: Comprehensive characterisation of
compartment-specific long non-coding RNAs associated with
pancreatic ductal adenocarcinoma. Gut. 68:499–511. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang F, Wang Y, Sun P, Wang ZQ, Wang DS,
Zhang DS, Wang FH, Fu JH, Xu RH and Li YH: Fibrinogen promotes
malignant biological tumor behavior involving
epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in
esophageal squamous cell carcinoma. J Cancer Res Clin Oncol.
143:2413–2424. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qi F, Liu X, Wu H, Yu X, Wei C, Huang X,
Ji G, Nie F and Wang K: Long noncoding AGAP2-AS1 is activated by
SP1 and promotes cell proliferation and invasion in gastric cancer.
J Hematol Oncol. 10:482017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Su C, Chen Z, Luo H, Su Y, Liu W, Cai L,
Wang T, Lei Y and Zhong B: Different patterns of NF-KB and Notch1
signaling contribute to tumor-induced lymphangiogenesis of
esophageal squamous cell carcinoma. J Exp Clin Cancer Res.
30:852011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han C, Fu Y, Zeng N, Yin J and Li Q:
LncRNA FAM83H-AS1 promotes triple-negative breast cancer
progression by regulating the miR-136-5p/metadherin axis. Aging
(Albany NY). 12:3594–3616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang HZ, Yin YF, Wan WJ, Xia D, Wang R
and Shen XM: Up-regulation of microRNA-136 induces apoptosis and
radiosensitivity of esophageal squamous cell carcinoma cells by
inhibiting the expression of MUC1. Exp Mol Pathol. 110:1042782019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gong YB and Zou YF: Clinical significance
of lncRNA FAM83H-AS1 in ovarian cancer. Eur Rev Med Pharmacol Sci.
23:4656–4662. 2019.PubMed/NCBI
|
